About 5 results found for searched term "NLRP3 Inflammasome Inhibitor I" (0.132 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M20412 | NLRP3 Inflammasome Inhibitor I | Immunology/Inflammation |
| NLRP3-IN-2 | ||
| NLRP3 Inflammasome Inhibitor I, an intermediate substrate in the synthesis of glyburide which is free of the cyclohexylurea moiety involved in insulin release, is a novel inhibitor of the NLRP3 inflammasome. | ||
| M4578 | Oridonin | NLR |
| Isodonol；NSC-250682 | ||
| Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Oridonin (NSC-250682) also acts as an inhibitor of AKT, with IC50 values of 8.4 and 8.9 μM for AKT1 and AKT2, respectively. | ||
| M30795 | INF4E | NLR |
| INF4E is a potent NLRP3 inflammasome inhibitor. INF4E inhibits caspase-1 and NLRP3 ATPase activities. INF4E shows protection against the IR-induced myocardial injury and dysfunction. | ||
| M30978 | Fc 11a-2 | NLR |
| Fc 11a-2, a benzimidazole compound, is an orally active and potent NLRP3 inflammasome inhibitor. Fc 11a-2 restrains the formation of NLRP3 inflammasome by inhibiting activation of caspase-1 and thus the activation of IL-1b/IL-18. Fc 11a-2 prevents the development of Dextran sulfate sodium (DSS)-induced murine experimental colitis. | ||
| M42016 | NLRP3-IN-17 | NLR |
| NLRP3-IN-17 is a potent, selective and orally active NLRP3 inflammasome inhibitor with an IC50 value of 7 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
